Quantum Biopharma (QNTM) Retained Earnings (2018 - 2026)
Quantum Biopharma (QNTM) reported Retained Earnings of -$211.8 million for Q1 2026, down 17.24% on a YoY basis from -$256.0 million in Q1 2025, and down 6.84% sequentially from -$198.3 million in Q4 2025.
Quantum Biopharma (QNTM) Retained Earnings (2018 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 9 years of Retained Earnings data on file, last reported at -$211.8 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 17.24% year-over-year to -$211.8 million; the trailing twelve-month figure through Mar 2026 stood at -$211.8 million (down 17.24% YoY), and the FY2025 full-year result was -$198.3 million, down 15.21% from the prior year.
- Retained Earnings declined to -$211.8 million in Q1 2026, from -$198.3 million in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$127.8 million in Q1 2022 to a low of -$211.8 million in Q1 2026.
- A 5-year average of -$165.4 million and a median of -$162.9 million in 2024 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings slipped 26.77% in 2022 and fell 4.84% in 2024, its largest moves.
- Tracing QNTM's Retained Earnings over 5 years: stood at -$144.2 million in 2022, then slipped by 8.56% to -$156.5 million in 2023, then decreased by 9.97% to -$172.1 million in 2024, then dropped by 15.21% to -$198.3 million in 2025, then fell by 6.84% to -$211.8 million in 2026.
- Business Quant data shows QNTM's Retained Earnings at -$211.8 million in Q1 2026, -$198.3 million in Q4 2025, and -$195.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - | -211.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -211.85 Mn |
| Dec 31, 2025 | -198.29 Mn |
| Sep 30, 2025 | -195.26 Mn |
| Jun 30, 2025 | -189.94 Mn |
| Mar 31, 2025 | -180.69 Mn |
| Dec 31, 2024 | -172.11 Mn |
| Sep 30, 2024 | -166.75 Mn |
| Jun 30, 2024 | -162.92 Mn |
| Sep 30, 2023 | -156.50 Mn |
| Jun 30, 2023 | -155.40 Mn |
| Mar 31, 2023 | -149.91 Mn |
| Dec 31, 2022 | -144.16 Mn |
| Sep 30, 2022 | -138.02 Mn |
| Jun 30, 2022 | -131.53 Mn |
| Mar 31, 2022 | -127.80 Mn |
| Dec 31, 2021 | -126.15 Mn |
| Sep 30, 2021 | -119.81 Mn |
| Jun 30, 2021 | -114.02 Mn |
| Mar 31, 2021 | -100.81 Mn |
| Dec 31, 2020 | -90.87 Mn |